Выбор редакции

Emergent Inks Deal with VaxInnate - Analyst Blog

Emergent BioSolutions signed a license agreement to gain an exclusive manufacturing right to VaxInnate Corporation's pandemic influenza vaccine candidate in the U.S.

НОВОСТИ ПО ТЕМЕ